Is Interleukin-1 Receptor Blockade Ready for Prime Time in Patients with Severe Sepsis and Macrophage Activation Syndrome?∗

Research output: Contribution to journalEditorialpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)443-444
Number of pages2
JournalCritical care medicine
Issue number2
StatePublished - Feb 1 2016


  • IL-1 receptor antagonist
  • macrophage activation syndrome
  • sepsis

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this